The new stent is designed to be used to palliate uncomfortable symptoms associated with colonic obstructions caused by malignant neoplasms and relieve large-bowel obstructions prior to colectomy procedures, according to the company.
“The new Evolution colonic stent reiterates Cook Medical’s commitment to pioneering a full line of efficient, effective products to improve the quality of life in patients who suffer discomfort or pain,” said Barry Slowey, global business unit leader for Cook Medical’s endoscopy division, in the release. “Now clinicians have the ability to precisely deploy and recapture colonic stents. That can make it easier to place the stent the first time around, potentially reducing the need for repeat procedures, while increasing efficiency in the GI unit.”
Cook Medical is headquartered in Bloomington, Ind.
Related Articles on FDA Clearances:
r4 Vascular Receives FDA Clearance for PTA Balloon
Intrinsic Medical Imaging Receives FDA Clearance for 3D Imaging Workstation
Teleflex Receives FDA Clearance for Peripherally Inserted Central Catheter
At the Becker’s 32nd Annual Meeting: The Business and Operations of ASCs, taking place October 29-31 in Chicago, ASC leaders, surgeons and healthcare executives will explore strategies to drive growth, enhance operational performance, navigate reimbursement challenges and prepare for the future of ambulatory surgery. Apply for complimentary registration now.